Needham Maintains I-Mab(IMAB.US) With Buy Rating, Cuts Target Price to $4
I-Mab Maintains Buy Rating Amid Strategic Refocus on Givastomig and Financial Stability
I-Mab Shares Are Trading Higher. The Stock May Be Reacting to a Disclosure That the Company Chairman Is Buying $2 Million Worth of Shares.
Express News | I-Mab Shares Are Trading Higher. The Stock May Be Reacting to a Disclosure That the Company Chairman Is Buying $2 Million Worth of Shares
I-Mab Announces Open Market Purchases of Company American Depositary Shares by Board Member
I-Mab Pauses CD73 Antibody Development in Pipeline Reshuffle
151158967 : Thank you, @Jaguar8 . Your hard work is appreciated!
103687630 : I think, what do you think of ONDS? There was good news on Wednesday but it went down. Do you think there is a chance for a rebound?
Jaguar8 OP 103687630 : I didn’t choose it because it didn’t specify how much is the contract.
103687630 Jaguar8 OP : Okay, thank you for your reply
70761249 : Can VERI make a breakthrough in the short term? The recent wildfires in Southern California are really heartbreaking, causing significant disappointment in the credibility of the media and government.
View more comments...